Kleiner Perkins

Activity from announced rounds

Activity in this selectionOct 25, 2026 · Biotech · Jan 1, 2026

Kleiner Perkins invests in technology companies from inception through IPO and beyond, combining early company formation with capital for later expansion.

The firm’s company-building work includes executive recruiting, business development and management systems. Its early work with Google included recruiting senior engineering and product leaders and introducing OKRs, giving a concrete example of how its role can extend beyond financing.

Its current AI thesis covers both foundational models and applications across industries. Kleiner’s investment in Anthropic reflects the former; its backing of enterprise products such as Rippling shows its interest in systems that become central to a customer’s operations.

Sources
Rounds participated in
3
Confirmed lead rounds
0
2 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$841M
3 disclosed · full round size, not this investor’s share

By stage

Series C+2
Seed1

By primary sector

Biotech2
Healthtech1

By country

United States3

Rounds

3 in this selection
Chai Discovery

Building AI models to accelerate pre-clinical drug discovery

$400MSeries C
Role not disclosed
NewLimit

NewLimit develops epigenetic reprogramming medicines designed to restore function in aging cells and treat age-related disease.

$435MSeries C
Participant
Health Universe

Provides AI infrastructure for healthcare organizations to integrate and govern autonomous agents

$6MSeed
Role not disclosed